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Available online 28 September 2011Abstract In animals, hypoxic preconditioning has been used as a form of neuroprotection. The exact mechanism involved in
neuroprotective hypoxic preconditioning has not been described, yet could be valuable for possible neuroprotective strategies.
The overexpression of the cystine-glutamate exchanger, system Xc−, has been demonstrated as being neuroprotective (Shih,
Erb et al. 2006). Here, using immunohistochemistry, we demonstrate that C57BL/6 mice exposed to hypoxia showed an in-
crease in system Xc− expression, with the highest level of intensity in the hippocampus. Western Blot analysis also showed
an almost 2-fold increase in system Xc− protein in hypoxia-exposed versus control mice. The mRNA for the regulatory subunit
of system Xc−, xCT, and the xCT/actin ratio were also increased under hypoxic conditions. Experiments using hypoxia-inducible
factor (HIF-1α) siRNA showed a statistically significant decrease in HIF-1α and system Xc− expression. Under hypoxic condi-
tions, system Xc− activity, as determined by cystine uptake, increased 2-fold. Importantly, hypoxic preconditioning was atten-
uated in neural stem cells by pharmacological inhibition of system Xc− activity with S4-carboxyphenylglycine. These data
provide the first evidence of hypoxic regulation of the cystine glutamate exchanger system Xc−.
© 2011 Elsevier B.V. All rights reserved.1. Introduction
Hypoxic preconditioning has been investigated as a neuro-
protective strategy although the exact details are not well
understood. Known mechanisms in this pathway involve the
upregulation of the hypoxia-inducible factor (HIF-1α) and
erythropoietin (Epo) (Kumral et al., 2003; Grimm et al.,⁎ Corresponding author at: Department of Pediatrics, Division of
Neonatology, UAB, 619 20th Street South, 525 New Hillman Building,
Birmingham, AL 35294, USA. Fax: +1 205 934 3100.
E-mail address: bsims@peds.uab.edu (B. Sims).
1873-5061/$ - see front matter © 2011 Elsevier B.V. All rights reserved.
doi:10.1016/j.scr.2011.09.0022005; Liu et al., 2005; Grimm et al., 2006), both of which
have been shown to be neuroprotective agents (Digicaylioglu
and Lipton, 2001; Buemi et al., 2002; Juul, 2002; Yu et al.,
2002; Kumral et al., 2003; Hasselblatt et al., 2006). The hyp-
oxia signaling cascade appears to be vital in preconditioning,
and several studies have demonstrated the importance of
HIF-1α. For example, inactivation of HIF-1α increased brain
injury (Baranova et al., 2007), and blocking HIF-1α activa-
tion with low-dose cadmium attenuated myocardial hypoxic
preconditioning (Belaidi et al., 2008). Additionally, other
agents such as insulin growth factor 1 (IGF-1) and cobalt
chloride have been shown to activate or increase HIF-1α
and lead to preconditioning (Wang et al., 2004; Xi et al.,
286 B. Sims et al.2004). Heat shock protein 27 (Hsp27) also increases HIF-1α
and causes protection against retinal ischemia (Whitlock et
al., 2005). In vitro studies in C6 glioma cells demonstrated
that increased HIF-1α decreased the insults caused by 3-
nitroproprionic acid (Yang and Levison, 2006).
To study this complex neuroprotective pathway, a common
endpoint needs to be identified. A potential pathway involves
the regulation of themajor cellular antioxidant glutathione. Glu-
tathione biosynthesis, which beginswith the import of cystine di-
mers through the cystine glutamate exchanger (System Xc−), is a
pivotal step in cellular metabolism, and cysteine availability is
the rate limiting to this process.
System Xc− is an important transmembrane protein responsi-
ble for the intracellular transport of cystine and the export of
glutamate. System Xc− is composed of two subunits, the regula-
tory subunit (4F2hc-CD98) and the catalytic subunit (xCT). The
catalytic subunit belongs to a family of transmembrane proteins
that have 12 transmembrane spanning regions. CD98 binds to
other amino acid transporters while xCT is considered the func-
tional portion of system Xc−. Because of this, xCT and system
Xc− will be used interchangeably.
There are several studies showing the importance of glu-
tathione and system Xc−. For example, the HIV-1 Tat protein
led to a decrease in glutathione and a concomitant increase
in system Xc− activity, producing a cell-state more vulnera-
ble to oxidative stresses (Bridges et al., 2004). High extra-
cellular glutamate concentrations inhibited system Xc− and
reduced glutathione levels in HT22 cells (Rossler et al.,
2004), and diethyl maleate increased the xCT gene at the
blood–brain barrier, causing an increase in L-cystine trans-
port (Hosoya et al., 2002). Increased xCT has been demon-
strated in retinal ganglion cells exposed to oxidative stress
(Dun et al., 2006), and inhibition of system Xc− activity in
cultured microglia cells prevented glutamate excitotoxicity
and facilitated neuroprotection (Qin et al., 2006). The
stress-induced transcription factor, NF-E2 related factor
(Nrf2) is considered a defense against oxidative stress and
has been shown to upregulate xCT, as well as other glutathi-
one synthesis/release components (Pacchioni et al., 2007).
Hypoxic preconditioning protects brains from future insults
but its exact mechanism has not been elucidated. We have
recently demonstrated that Epo-induced neuroprotection
requires system Xc− activity (Sims et al., 2010), and others
have shown that overexpression of xCT is neuroprotective
against oxidative stress (Shih et al., 2006).
Given the possible importance of system Xc− in the neuro-
protective mechanism of hypoxic preconditioning, the cur-
rent study examined the role of system Xc− activity and
protein expression during hypoxia. Understanding the regu-
lation of system Xc− activity in vivo could prove to be a
novel neuroprotective strategy.2. Results
To examine the expression of the cystine glutamate exchanger,
postnatal day 7 (PND 7) C57BL/6 mice were exposed to either
hypoxia (10% oxygen, treatment group) or normal room air (con-
trol group) for 24 h. Animals were sacrificed and brain sections
were stained for system Xc−. Fig. 1A shows that system Xc− ex-
pression increased in animals placed in hypoxia compared to
those exposed to normal room air. This increase was mostapparent in the hippocampus. Whole brain lysates were collect-
ed from both groups of mice for Western Blot analysis of xCT and
actin using a standard densitometer (Fig. 1B). The xCT/actin
ratio increased by almost 2-fold in the hypoxic mice (0.89±0.1
in control versus 1.62±0.31 in hypoxia animals).
To test if the increase in system Xc− expression was due to an
increase in translational or post-translational regulation of sys-
temXc−mRNA, total RNAwas collected fromwhole brain of con-
trol and hypoxic C57BL/6 mice for real-time PCR analysis. There
was an 8-fold increase in xCT mRNA in brains of hypoxic mice
compared to those of control mice (Fig. 1D).
For system Xc− regulation to be a practical tool for neuro-
protection, it must respond in a timely fashion. However,
the time course of system Xc− expression during hypoxia is
not known. The current experiment was designed to address
if system Xc− expression would increase after a short expo-
sure to hypoxia and the time course of this response. PND 7
mice were placed in 10% hypoxia for 45 min, and samples
were collected from 0 to 24 h. Animals were sacrificed,
and the right cortex was immediately dissected on ice and
placed in lysis buffer at the specified time point. Samples
were frozen at −20 °C until all time points were collected.
Fig. 2A shows a representative Western Blot of both xCT
and actin at 0 (1), 4 (2), 8 (3), 12 (4) and 24 (5)h. Fig. 2B is
the xCT/actin ratio for all samples. The xCT/actin ratio
was 5.64±0.51 (p≤0.01) at 4, 4.61±0.69 (p≤0.01) at 8,
6.49±1.36 (p≤0.01) at 12, and 5.08±1.37 (p≤0.05) at
24 h. These data show that there was a persistent elevation
in xCT after a short exposure to hypoxia.
The mechanism of the system Xc− increase may be linked
to the hypoxia signaling cascade. Hypoxia increases HIF-1α
which leads to an increase in multiple genes. In order to
demonstrate the role of HIF-1α signaling in xCT regulation
we probed blots from 10% hypoxia treated cells with HIF-
1α siRNA for both HIF-1 α (Fig. 3A) and xCT (Fig. 3B). ΗIF-
1α siRNA was added at 10 or 20 ng/ml to B104 cells and the
effect of HIF-1α knockdown on HIF-1α (Fig. 3A) and xCT
(Fig. 3B) was examined. HIF-1α siRNA resulted in a 53% and
73% decrease in HIF-1α band intensity at 10 ng/ml
(p≤0.05) and 20 ng/ml (p≤0.05), respectively (Fig. 3A). In
addition, xCT band intensity at 20 ng/ml was significantly
decreased by 34% (p≤0.05, Fig. 3C), suggesting that xCT is
linked directly to this pathway downstream of HIF-1α.
To investigate the involvement of system Xc− expression
in hypoxic preconditioning, we performed a hypoxic precon-
ditioning experiment using differentiated mouse neural stem
cells. Cells were placed in a 10% hypoxia chamber for 4 h
then placed in room air under excitotoxic conditions (3 mM
glutamate) overnight. Control cells at room air exposed to
glutamate had 61% cell loss (p≤0.01, Fig. 4 (gray bars)). In
contrast, cells exposed to hypoxia pretreatment before glu-
tamate exposure showed similar cell counts to cells not ex-
posed to glutamate (Fig. 4 (black bars)). In the presence of
S4-CPG (500 μM), a system Xc− inhibitor, cells that received
hypoxic preconditioning had total cell counts similar to the
non-hypoxic cells treated with S4-CPG. To further determine
if hypoxic preconditioning involved glutathione biosynthesis,
we inhibited glutathione biosynthesis with buthionine sul-
foximine (BSO). Hypoxic preconditioning had no protective
effect if S4-CPG or BSO was used.
Expression of system Xc− under hypoxic conditions has been
















































Figure 1 System Xc− expression in neonatal mouse brain. A) Immunohistochemistry of mouse hippocampus under hypoxic and room
air conditions. B) Western Blot of whole mouse brain under control and hypoxic conditions. C) xCT/actin ratio of three Western Blots.
Real time PCR of system Xc− in control versus hypoxic whole mouse brain samples. D) xCT mRNA fold increase. *p≤0.05 determined
by paired Student's t test.
287Hypoxic preconditioning involves system Xc− regulation in mouse neural stem cellsneural stem cells were placed in 10% hypoxia for 4 h then placed
overnight and collected the next day for cystine uptake mea-
surement. Cystine uptake experiments showed an increase in
fluorescence after hypoxic exposure. Fluorescence increased
by about two-fold in hypoxia (373 fluorescence units/mg pro-
tein) versus control (182 fluorescence units/mg protein)
(p≤0.05, Fig. 5A). These data suggest that system Xc− activity
is regulated by hypoxia. Fig. 5B describes amodel of hypoxic reg-
ulation of System Xc.3. Discussion
Our current study was designed to understand a specific mecha-
nism involved in the neuroprotective effects of hypoxic precon-
ditioning. System Xc− is pivotal in glutathione biosynthesis andan increase in system Xc− activity has been associated with neu-
roprotection (Shih et al., 2006). We therefore hypothesized that
this pathway could be critical for neuroprotection. Herewe show
that, in vivo, hypoxia increased both system Xc− protein and
mRNA expression, and the increased xCT could persist for up to
24 h after only a brief hypoxic exposure. We also demonstrate
in vitro that xCT may be linked to HIF-1α, since knocking down
HIF-1α in B104 cells inhibited xCT expression. Further, differen-
tiated mouse neural stem cells showed hypoxia-induced in-
creases in system Xc− activity and were protected against
glutamate-induced excitotoxicity when exposed to hypoxic con-
ditions. This hypoxia-related protection was lost when system
Xc− was inhibited or glutathione synthesis was blocked.
Hypoxic preconditioninghasbeen showntobeneuroprotective.
For example, in ischemic rat brain, embryonic stem cells trans-
planted after being exposed to hypoxic preconditioning protected
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Figure 2 Immunoblot of hypoxic right cortex. A) Time course:
0, 4, 8, 12 and 24 h. B) xCT/actin ratio. *p≤0.05 and **p≤0.01
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Figure 3 Effect of HIF-1α knockdown on xCT expression in
B104 cells. A) HIF-1α normalized band density after HIF-1 α
knockdown. B) xCT normalized band intensity after HIF-1α
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Figure 4 System Xc− pharmacological inhibition during hyp-
oxic preconditioning in differentiated neural stem cells. Dif-
ferentiated neural stem cells under room air conditions (gray):
1, control; 2, 3 mM glutamate; 3, 3 mM glutamate+500 μM S4-
carboxyphenylglycine; 4, 3 mM glutamate+200 μMbuthionine sul-
foximine. Differentiated neural stem cells under hypoxic condi-
tions (black): 1, control; 2, 3 mM glutamate; 3, 3 mM glutamate+
500 μM S4-carboxyphenylglycine; 4, 3 mM glutamate+200 μM
buthionine sulfoximine. * p≤0.05 determined by paired Student's
t test.
288 B. Sims et al.the ischemic brain much more than did control cells, with 30–40%
less cell death (Theus et al., 2008). Peroxide is considered a poten-
tial cause of brain injury in hypoxic ischemic encephalopathy by
causing an increase in glutathione peroxidase, which changes dur-
ing preconditioning (Sheldon et al., 2007). Peroxidemay also have
some protective effect at certain levels (Furuichi et al., 2005).
However, no studies have investigated the role of system Xc− in
this process. In the current study,mouse brain slices showed a dra-
matic increase in system Xc− immunoreactivity, and Western Blot
analysis also showedanalmost 2-fold increase in systemXc− immu-
noreactivity inwholebrain duringhypoxia. Interestingly, therewas
an even more robust increase in mRNA. Collectively, these data
suggest that there may be a need for system Xc− expression/
activity during hypoxia that may provide neuroprotection.
The neuroprotective effect of hypoxic preconditioning in
the brain has been studied by several groups who found evi-
dence for the involvement of HIF-1α and its downstream tar-
gets and/or Epo (He et al., 2008) (Liu et al., 2005; Theus
et al., 2008) (Prass et al., 2003) (Bernaudin et al., 2002).
In hyperbaric preconditioning there is tolerance after hypox-
ia that is linked to the upregulation of HIF-1α (Peng et al.,
2008), and infusion of soluble EpoR reduced the protective
effect seen in mouse brain (Prass et al., 2003). Stresses in-
volving excitotoxicity are attenuated by hypoxic precondi-
tioning through the upregulation of NF-κΒ and antioxidative
enzymes (Wang et al., 2005). Indeed, the protective effect
of Epo in hypoxic preconditioning was shown to be effected











































Figure 5 A) C14-cystine uptake in room air and hypoxic pre-
conditioned neural stem cells. B) Possible system Xc regulation
schematic. *p≤0.05 determined by paired Student's t test.
289Hypoxic preconditioning involves system Xc− regulation in mouse neural stem cellsGiven the involvement of HIF-1α, a plausible explanation to
the link between systemXc− and hypoxia is through the hypox-
ia signaling cascade involving HIF-1α. As demonstrated by the
localization, neurons tend to have a robust increase in system
Xc− after hypoxic stimulation and this may involve HIF-1α.
Thus, we targeted HIF-1α in B104 neuroblastoma cells with a
siRNA probe designed to knockdown HIF-1α mRNA and subse-
quently protein. The correlation demonstrates that system
Xc− is a downstream target of HIF1-α signaling. This is the
first direct evidence linking system Xc− expression with HIF-
1α. The current study shows that system Xc− appears to be
regulated through the HIF-1α pathway and, by our previous re-
port (Sims et al., 2010), through Epo. These data beg the ques-
tion: can system Xc− alone produce neuroprotection? Shih
et al. (2006) showed that xCT overexpression caused neuro-
protection, further suggesting that this mechanism may be a
novel neuroprotective strategy.
We also determined if hypoxic preconditioning would occur
if system Xc− was pharmacologically inhibited. Differentiated
neural stem cells were exposed to hypoxia for 4 h and then
treated with a toxic concentration of glutamate. In the pres-
ence of hypoxic preconditioning, the cells survived while
those not exposed to hypoxia showed significant cell loss.
Moreover, when system Xc− was inhibited or glutathione bio-
synthesis blocked, hypoxic preconditioning was not protective
and cells did not survive the excitotoxic conditions. These
data support the hypothesis that system Xc− activity, and glu-
tathione synthesis, is required for protective effects of hypox-
ic preconditioning. Future studies will be aimed at looking at
other regulators of this important protein which could give
better insight into a possible protective pathway.4. Materials and methods
All reagents were ordered from Sigma-Aldrich (St. Louis, MO)
unless otherwise stated. Antibodies were ordered from Che-
micon unless otherwise stated. C57BL/6 mice were obtained
from Charles River Laboratories (Wilmington, MA). All proto-
cols were approved by the Institutional Animal Care and Use
Committee (IACUC) of UAB, and are consistent with the PHS
policy on Humane Care and Use of Laboratory Animals (Of-
fice of Laboratory Animal Welfare, Aug 2002) and the
Guide for the Care and Use of Laboratory Animals (National
Research Council, National Academy Press, 1996). B104
cells were a gift from Dr. Vince Gallo.
4.1. In vivo hypoxia
Cells were cultured in plexiglass hypoxia chamber at 10% for
4 h. Animals were placed in larger plexiglass chamber for 4 h
at desired oxygen concentration. The oxygen percentage
was monitored throughout experiment.
4.2. Western Blot
Cells were triturated and pelleted then lysed with RIPA buff-
er [150 mM NaCl, 1% Nonidet P-40, 0.1% SDS and 50 mM Tris
(pH 8.0)]. Twenty-five micrograms of protein was collected
and run on a Bio-Rad Ready Gel Tris 10% HCL. Samples
were run at 120 V for 45 min on ice and transferred to nitro-
cellulose using the Trans Blot Semi-Dry apparatus for 15 min
at 15 V and probed for the appropriate antibody. Primary an-
tibodies were used at 1:1000 dilutions in 3% goat serum. Sec-
ondary antibodies were also used at 1:1000 dilution in TBST
(8 g NaCl, 0.2 g KCl, 3 g Tris, 1 ml of Tween 20 in 1 L pH
7.4) for 1 h on a rotator. Blots were developed using the
Pierce Super signal and standard film with a Kodak
developer.
4.3. Real time polymerase chain reaction
Total RNA was prepared using the Trizol reagent and protocol.
One microgram of total RNA was used for each experiment.
GAPDH and xCT primers (Integrated DNA Technology) with the
following sequencewere used: xCT, forward 5′-CCTGGCATTTG-
GACGCTACAT-3′, reverse 5′-TGAGAATTGCTGTGAGCTTGCA-3′;
and GAPDH, forward 5′-TTGTCTCCTGCGACTTCAAC-3′, reverse
5′-ACCAGGAAATGAGCTTGACA-3′. ABI Prism 7000 was used for
all real time PCR experiments and data were analyzed using
the Pfaffel method (2ΔΔCT).
4.4. Immunohistochemistry
Primary antibodies for immunohistochemistry included Actin
(MAB1501-Chemicon), System Xc (Novus Biological), GFAP
(NB300-141-Novus Biological), and NeuN (MAB377-Chemicon)
and were used at 1:1000 overnight. Sections were stained
by immunofluorescence using FITC and Cy3-conjugated sec-
ondary antibodies at 1:1000 for 2 h. Nonspecific IgG and
omission of primary antibody were used as controls for the
staining specificity. To avoid bias, observers estimating
290 B. Sims et al.immunohistochemistry staining were blind to treatment con-
ditions and the same exposure time was used for all slides.
4.5. siRNA production
Using primers designed with the Block-It siRNA program from
Invitrogen for HIF-1α, siRNA was made using the Ribomax T7
RNA Polymerase System. Cells were then transfected with
siRNA using the CodeBreaker siRNA Transfection Reagent
protocol. Cells were grown for 24–48 h and then lysed for
Western Blot analysis. RNA was normalized using the
Quant-it Ribogreen RNA quantification kit.
4.6. Cortical neural stem cells
Cryopreserved Mouse Cortical Neural Stem Cells were
obtained from Chemicon (Catalog Number SCR029). Polyor-
nithine–laminin coated plates were made using concentra-
tions of polyornithine (10 mg/ml) and laminin (5 μg/ml).
Plates were incubated with polyornithine overnight,
washed, and laminin solution was added and plates were
allowed to incubate overnight before being used directly or
stored at −80 °C. In brief, cells were grown in Neural Stem
Cell Expansion Medium (Chemicon Neural Stem Cell Medium,
20 ng/ml Fibroblast Growth Factor 2 (FGF-2), 20 ng/ml Epi-
dermal Growth Factor (EGF), and 2 μg/ml heparin) and pas-
saged every 3–5 days. Cells were allowed to grow to 80%
confluence then split 1:3 into T25cm flasks. Differentiation
was done after passage 3. Differentiation was induced by
withdrawing EGF, FGF-2, and heparin, and cells were
allowed to reach 70% confluence.
4.7. Cystine uptake
Cystine uptake was done using conditions described in Sims
et al. (2010). C14 Cystine (2.5 μCi/ml) was added to the sam-
ple and a C14 detection program was used to determine total
radioactivity.
4.8. Statistical analysis
Statistical analysis was performed using the Student's t-test
comparing all samples to control. Data are presented as
mean±standard deviation with each experiment being
done in triplicate. Statistical significance was set at p≤0.05.
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